I
INVO Fertility, Inc. (IVF)
NCM – Real Time Price. Currency in USD
2.68
-0.20 (-7.11%)
At close: Mar 27, 2026, 4:00 PM EDT
2.73
+0.05 (1.87%)
After-hours: Mar 27, 2026, 7:33 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.68
-0.20 (-7.11%)
At close: Mar 27, 2026, 4:00 PM EDT
2.73
+0.05 (1.87%)
After-hours: Mar 27, 2026, 7:33 PM EDT
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
| Name | Position |
|---|---|
| Mr. Andrea Goren | Chief Business Officer |
| Mr. Steven M. Shum | CEO & Director |
| Ms. Terah Krigsvold | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-02-02 | S-1 | forms-1.htm |
| 2026-01-30 | 8-K | form8-k.htm |
| 2026-01-26 | 8-K | form8-k.htm |
| 2026-01-06 | 8-K | form8-k.htm |
| 2025-12-30 | DEFA14A | formdefa14a.htm |
| 2025-12-18 | DEF 14A | formdef14a.htm |
| 2025-12-17 | S-1 | forms-1.htm |
| 2025-12-08 | PRE 14A | formpre14a.htm |
| 2025-12-05 | 8-K | form8-k.htm |
| 2025-12-03 | 8-K | form8-k.htm |